AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18603457
Drug: Cannabinoid (delta‐9‐tetrahydrocannabinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabinoid (delta‐9‐tetrahydrocannabinol (THC) and cannabidiol mixture) as an oromucosal spray
Trial: 16299295
Drug: MSP3-LSP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSP3-LSP vaccine with Montanide ISA 720
Trial: 16299295
Drug: MSP3-LSP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSP3-LSP vaccine with aluminum hydroxide
Trial: 16299295
Drug: MSP3-LSP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSP3-LSP vaccine
Trial: 12435326
Drug: Pharmacological therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological therapies for OA
Trial: 12435326
Drug: Cochrane systematic
RxNorm normalized name: Integrase Inhibitors, antiinfectives for systematic use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochrane systematic reviews of OA therapies
Trial: 9790423
Drug: Benznidazole at
RxNorm normalized name: benznidazole
DrugBank: Benznidazole (DB11989)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benznidazole at a dose of 5 mg/kg/day for 60 days
Trial: 7199836
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg of morphine epidurally
Trial: 7199836
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg of morphine intramuscularly
Trial: 28651804
Drug: Trabectedin 1.5mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabectedin 1.5mg/m2 by 24‐hour IV infusion
Trial: 28651804
Drug: Dacarbazine 1g/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacarbazine 1g/m2 by 20‐120‐minute IV infusion once every three weeks
Trial: 25015203
Drug: Long-course preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course preoperative CRT (50.4 Gy in 28 fractions, per oral tegafur-uracil and L-leucovorin)
Trial: 11447952
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg ketamine + 0.1 mg/kg diazepam
Trial: 9727815
Drug: Thrice weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice weekly buprenorphine maintenance in primary care clinic
Trial: 9727815
Drug: Traditional drug
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional drug treatment program
Trial: 2683836
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) 4 puffs of 50 micrograms b.i.d.
Trial: 1114148
Drug: Salbutamol (predominantly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (predominantly β‐2 stimulant)
Trial: 1114148
Drug: Practolol (predominantly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol (predominantly β‐1 blocking agent) with Salbutamol
Trial: 24535377
Drug: β-blocker therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blocker therapy
Trial: 24080100
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment (scaling and root planing for a minimum of two 90-minute sessions, plus antibacterial mouth rinse for at least 32 days)
Trial: 24080100
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received periodontal treatment after 6 months)
Trial: 20847112
Drug: Tea tree
RxNorm normalized name: tea tree
DrugBank: Melaleuca alternifolia leaf (DB14372)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea tree oil treatment
Trial: 7828454
Drug: Methionyl growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionyl growth hormone (0.3 mg/kg/week) administered daily
Trial: 7828454
Drug: Methionyl growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionyl growth hormone (0.3 mg/kg/week) administered 3 times per week (TIW)
Trial: 3513581
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone (4 capsules of 100 mg each)
Trial: 3513581
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 capsules)
Trial: 3513581
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone
Trial: 22954616
Drug: Org 26576
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26576 (450 mg BID)
Trial: 22954616
Drug: Org 26576
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26576 (400 mg BID)
Trial: 20195651
Drug: Bracing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bracing treatment for idiopathic scoliosis
Trial: 20195651
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (existing treatment)
Trial: 10461109
Drug: Tamm‐Horsfall protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamm‐Horsfall protein excretion in pure uric acid stone formers
Trial: 10461109
Drug: Uric acid
RxNorm normalized name: Uric acid
DrugBank: Uric acid (DB08844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uric acid excretion in pure uric acid stone formers (group I)
Trial: 10461109
Drug: Uric acid
RxNorm normalized name: Uric acid
DrugBank: Uric acid (DB08844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uric acid excretion in mixed stone formers (group II)
Trial: 10461109
Drug: Calcium excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium excretion in mixed stone formers (group II)
Trial: 10461109
Drug: Citrate excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrate excretion in both groups (I and II)
Trial: 8903836
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 3 IU m‐2 daily
Trial: 8903836
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 6 IU m‐2 daily
Trial: 26151676
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate 1,000 mg plus prednisone/prednisolone 5 mg twice daily
Trial: 26151676
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus prednisone/prednisolone 5 mg twice daily
Trial: 19917838
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF)
Trial: 19917838
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin and fluorouracil (PF)
Trial: 12752352
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g sachet (micropellets) mesalazine formulation
Trial: 12752352
Drug: Three enteric‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three enteric‐coated tablets (500 mg each, Claversal)
Trial: 9311056
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (2 x 1,000 micrograms/day)
Trial: 3487259
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg bw methylprednisolone
Trial: 3487259
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg bw dexamethasone
Trial: 3487259
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg hydrocortisone
Trial: 16570889
Drug: Auto-transfusion system
RxNorm normalized name: Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auto-transfusion system with re-infusion of drained blood
Trial: 16570889
Drug: Methylprednisolone administration
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone administration before blood re-perfusion
Trial: 10930149
Drug: AZT 100
RxNorm normalized name: AZT 100 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZT 100 mg three times daily plus ddC 0.375 mg three times daily (half dose)
Trial: 10930149
Drug: AZT 200
RxNorm normalized name: AZT 200 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZT 200 mg three times daily plus ddC 0.75 mg three times daily (standard dose)
Trial: 8436638
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg bid) under supervision
Trial: 27550537
Drug: Lycopene-enriched virgin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene-enriched virgin olive oil spray (n = 30)
Trial: 27550537
Drug: Placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo spray (n = 30)
Trial: 23789370
Drug: Rectal suppositories
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal suppositories vitaprost plus once a day for 10 days before and after surgery
Trial: 23789370
Drug: Pefloxacin 400
RxNorm normalized name: pefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin 400 mg 2 times a day for 10 days before and after surgery (Control group)
Trial: 23789370
Drug: Rectal suppositories
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal suppositories vitaprost plus
Trial: 23789370
Drug: Pefloxacin 400
RxNorm normalized name: pefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin 400 mg 2 times a day (Control group)
Trial: 21972621
Drug: Medication (Enteric-coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Enteric-coated aspirin)
Trial: 15533466
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTX‐A) injection (100 to 200 U of Dysport or Botox)
Trial: 30829777
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTX‐A) injection
Trial: 8116561
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of fructose
Trial: 1753719
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg caffeine
Trial: 31398441
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg caffeine
Trial: 20399993
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of Mycophenolate mofetil (MMF) 500 mg
Trial: 20399993
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of Mycophenolate mofetil (MMF) 500 mg
Trial: 18397979
Drug: Outpatient 1-year
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient 1-year intervention program based on exercise, behavior, and nutrition therapy
Trial: 2009843
Drug: Triazolam, 0.125
RxNorm normalized name: Triazolam, 0.125 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam, 0.125 mg
Trial: 16635226
Drug: Motilin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Motilin infusion
Trial: 6128230
Drug: Somatostatin and
RxNorm normalized name: Somatostatin and analogues
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin and motilin together infusion
Trial: 21320549
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of PCV7
Trial: 21320549
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of PCV7
Trial: 22326775
Drug: One or
RxNorm normalized name: Geone Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One or two doses of PCV7
Trial: 17601990
Drug: Euglycemic-hyperinsulinemic clamp
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euglycemic-hyperinsulinemic clamp (1.2 mU x kg(‐1) x min(‐1) insulin)
Trial: 16518992
Drug: Fasting plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting plasma glucose (FPG) levels of 93-99 mg/dl
Trial: 16518992
Drug: Fasting plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting plasma glucose (FPG) levels of 100-125 mg/dl
Trial: 10529122
Drug: 5 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 microg/kg of recombinant human IL-10 (rhIL-10) daily for 28 days
Trial: 10529122
Drug: 10 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg/kg of recombinant human IL-10 (rhIL-10) daily for 28 days
Trial: 8622104
Drug: Isepamicin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isepamicin (15 mg/kg or 8 mg/kg once daily)
Trial: 8622116
Drug: Amikacin (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin (7.5 mg/kg twice daily)
Trial: 31911147
Drug: Islatravir (0.5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Islatravir (0.5-30 mg single oral dose)
Trial: 31911147
Drug: Islatravir (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Islatravir (10 mg dose)
Trial: 31911147
Drug: Islatravir (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Islatravir (0.5 mg dose)
Trial: 21362575
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil (standard preparation, 50:50 medium‐chain triacylglycerols: soybean oil)
Trial: 18640856
Drug: Acetaminophen extended-release
RxNorm normalized name: Acetaminophen Extended-Release
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen extended-release (APAP ER) 3900 mg daily
Trial: 18640856
Drug: Rofecoxib 12.5
RxNorm normalized name: rofecoxib 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 12.5 mg daily
Trial: 17538978
Drug: Neoadjuvant endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant endocrine therapy with aromatase inhibitors (anastrozole 1 mg/day or exemestane 25 mg/day for 3 months)
Trial: 17538978
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (doxorubicin 60 mg/m(2) with paclitaxel 200 mg/m(2) for four 3-week cycles)
Trial: 14738791
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (500 mg per day for 5 days)
Trial: 15801935
Drug: CHF3381 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF3381 400 mg twice daily
Trial: 15801935
Drug: CHF3381 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF3381 100 mg twice daily
Trial: 15801935
Drug: CHF3381 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF3381 200 mg twice daily
Trial: 10477360
Drug: Carbohydrate‐arginine (CHO/AA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate‐arginine (CHO/AA) supplement (1 g carbohydrate/kg body mass and 0.08 g arginine‐hydrochloride/kg body weight)
Trial: 10477360
Drug: Carbohydrate (CHO)
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (CHO) supplement (1 g carbohydrate/kg body weight)
Trial: 30837170
Drug: Adjuvanted vaccine
RxNorm normalized name: PIKA-adjuvanted vaccine composition
DrugBank: PIKA rabies vaccine (DB17963)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted vaccine with 45 μg of LTh(αK)
Trial: 30837170
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (22.5 μg of influenza HA antigen alone)
Trial: 27586538
Drug: (S)-amlodipine (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-amlodipine (2.5-5 mg)
Trial: 27586538
Drug: Conventional amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional amlodipine (5-10 mg)
Trial: 9613231
Drug: Blink-concurrent glissadic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blink-concurrent glissadic saccades
Trial: 9283511
Drug: Yohimbine hydrochloride
RxNorm normalized name: Yohimbine Hydrochloride
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine hydrochloride (0.4 mg/kg)
Trial: 16873702
Drug: rhIGF-I/IGFBP-3 (0.1-0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIGF-I/IGFBP-3 (0.1-0.8 mg x kg(-1) x day(-1))
Trial: 10678614
Drug: High-dose fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fluticasone propionate (1,000 microg x day(‐1))
Trial: 10678614
Drug: Low-dose fluticasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluticasone propionate (100 microg x day(‐1))
Trial: 10678614
Drug: Placebo (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (after 6 weeks of FP treatment)
Trial: 9042816
Drug: beta-carotene (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-carotene (15 mg daily)
Trial: 8366412
Drug: Collagen membrane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen membrane barrier therapy
Trial: 3788816
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of dipyridamole
Trial: 3788816
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of ASA
Trial: 3788816
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of dipyridamole and 25 mg of ASA together
Trial: 20207239
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1 g) and Vitamin E (400 IU) supplementation
Trial: 27270566
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac
Trial: 12450888
Drug: Mixed alpha‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed alpha‐ plus gamma‐tocotrienol supplement
Trial: 7439253
Drug: Phenazone (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenazone (1.0 g X 4 for 2 days, then 0.5 g X 4 for the next 2 days)
Trial: 24741050
Drug: Alprazolam (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (single oral dose)
Trial: 24741050
Drug: Zolpidem (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (single oral dose)
Trial: 17618955
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of a mix of inulin and oligofructose (9 subjects)
Trial: 15632028
Drug: 2D gated
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2D gated acquisitions (2D-G)
Trial: 12358656
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam 0.1 mg.kg‐1
Trial: 12212217
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg.kg‐1
Trial: 7782427
Drug: D‐tryptophan‐6‐luteinizing hormone‐releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐tryptophan‐6‐luteinizing hormone‐releasing hormone (D‐Trp‐6‐LHRH) depot (Decapeptyl 3.75) for 6 months
Trial: 7782427
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive containing 30 micrograms of ethinyl oestradiol plus 150 micrograms of desogestrel for 12 months after GnRHa therapy
Trial: 23590327
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care physical therapy
Trial: 30565544
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment by primary care physician
Trial: 25038977
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 30, 50 or 70 mg/day
Trial: 19025526
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO(4)) infusion
Trial: 11477460
Drug: Lycopene (13.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene (13.3 mg)
Trial: 10878653
Drug: Carotene mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotene mixture (11.9 mg)
Trial: 4020675
Drug: Acetaminophen with
RxNorm normalized name: acetaminophen with codeine ORAL ELIXIR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen with probenecid (500 mg every 6 hr)
Trial: 4020675
Drug: Acetaminophen without
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen without probenecid